Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
Human Pathology|May 26, 2012
Description of 2 angiogenic phenotypes in clear cell renal cell carcinomaJulien Edeline, Stéphanie Mottier, Cécile Vigneau, et al.
Medical Oncology (Northwood, London, England)|April 19, 2011
Cementoplasty for painful bone metastases: a series of 42 casesEstelle Botton, Julien Edeline, Yan Rolland, et al.
Journal of Cancer Research and Clinical Oncology|February 11, 2012
Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell linesBénédicte Martin, Julien Edeline, Jean-Jacques Patard, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 21, 2019
Medical treatment for cholangiocarcinomaJorge Adeva, Bruno Sangro, Maximiliano Salati, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2026
Machine learning models classifiers enable a strong prediction of radioembolization-induced liver disease, and define a new bilirubin threshold for selection of patientsItzel Rivera, Heloïse Bourien, Ewan Morel-Corlu, et al.
Anticancer Research|September 12, 2013
In vitro demonstration of synergy/additivity between (188)rhenium and sorafenib on hepatoma lines: preliminary resultsMarc Pracht, Julien Edeline, Nicolas Lepareur, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2012
Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolizationLaurence Lenoir, Julien Edeline, Yann Rolland, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2015
Occupational radiation exposure of medical staff performing ⁹⁰Y-loaded microsphere radioembolizationSophie Laffont, Yan Rolland, Valérie Ardisson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2012
Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary resultsEtienne Garin, Laurence Lenoir, Yan Rolland, et al.
JHEP Reports : Innovation in Hepatology|May 13, 2026
Second-Line TKI after First-Line Immunotherapy-based Treatment in Advanced HCC: Reconstructed IPD Meta-analysisErman Akkus, Christian Hobeika, Julien Edeline, et al.
Pageof 16